Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CINC

CinCor Pharma (CINC) Stock Price, News & Analysis

CinCor Pharma logo

About CinCor Pharma Stock (NASDAQ:CINC)

Advanced Chart

Key Stats

Today's Range
$29.02
$29.35
50-Day Range
$28.73
$29.56
52-Week Range
$10.53
$43.15
Volume
6.35 million shs
Average Volume
818,447 shs
Market Capitalization
$1.27 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial to treat chronic kidney diseases. The company was incorporated in 2018 and is based in Waltham, Massachusetts.

Receive CINC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CinCor Pharma and its competitors with MarketBeat's FREE daily newsletter.

CINC Stock News Headlines

This document could hand you a shot at $915 every single weekend!
Something fascinating happens in the options market when most traders aren't paying attention… While everyone else collects standard daily premiums Monday through Friday... There's a special opportunity to target TRIPLE premiums just for holding positions over the weekend. Think about that... Most traders get one day's worth of premium for their trades. But by entering right before the weekend, when everything works out, you could collect THREE days worth - even though markets are closed for two of them. Thanks to a special discovery by a Wall Street legend who helped manage a $1.7 trillion firm – regular folks like you can now target extra cash from the markets on weekends… Just like he showed his small group of traders on December 20th with KO... A quick 2-minute setup Friday afternoon… Head out for the weekend... Monday morning? An extra $1,111 sitting in the account (with a $5k starting stake).
CinCor Pharma Inc.
Impel Pharmaceuticals hit by another C-suite departure
See More Headlines

CINC Stock Analysis - Frequently Asked Questions

CinCor Pharma (CINC) raised $176 million in an IPO on the week of November 7th 2022. The company issued 11,000,000 shares at a price of $15.00-$17.00 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that CinCor Pharma investors own include ARMOUR Residential REIT (ARR), AstraZeneca (AZN), AGNC Investment (AGNC), Amgen (AMGN), Broadcom (AVGO), Costco Wholesale (COST) and Cisco Systems (CSCO).

Company Calendar

Today
5/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:CINC
Fax
N/A
Employees
15
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$50.37 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
($1.74) per share
Price / Book
-16.70

Miscellaneous

Free Float
36,937,000
Market Cap
$1.27 billion
Optionable
Not Optionable
Beta
N/A
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:CINC) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners